CD134

• CD134 is a co-stimulatory receptor, also known as OX40, primarily expressed on activated T cells.
• It belongs to the tumor necrosis factor receptor (TNFR) superfamily.
• The binding of CD134 to its ligand, OX40L, enhances T-cell proliferation, survival, and cytokine production.
• CD134 plays a critical role in shaping the magnitude and duration of immune responses against infections and cancer.
• Its activity is implicated in various immune-mediated diseases, making it a target for therapeutic interventions.

What is CD134: The OX40 Receptor

CD134 refers to a cell surface glycoprotein that is a member of the tumor necrosis factor receptor (TNFR) superfamily. It is more commonly known as the OX40 receptor. This receptor is primarily expressed on activated CD4+ and CD8+ T lymphocytes, which are key players in the adaptive immune system. Its expression is typically low or absent on resting T cells but is rapidly upregulated following T-cell activation through the T-cell receptor (TCR) and co-stimulatory signals.

The interaction of the CD134 receptor with its cognate ligand, OX40L (CD252), which is found on antigen-presenting cells (APCs) such as dendritic cells, B cells, and macrophages, is essential for providing a secondary co-stimulatory signal to T cells. This signal is distinct from the primary signal delivered by the TCR and is critical for fine-tuning the immune response. Understanding this molecular interaction is fundamental to comprehending T-cell biology and immune regulation.

CD134’s Role and Biological Significance in the Immune System

The primary CD134 protein function is to act as a co-stimulatory molecule that enhances T-cell activation, survival, and proliferation. When CD134 on activated T cells binds to OX40L on antigen-presenting cells, it delivers a potent signal that promotes the expansion of effector T cells and the development of memory T cells. This interaction is crucial for sustaining robust immune responses, particularly during chronic infections or in the context of anti-tumor immunity.

The CD134 role in immune system extends to several key aspects of T-cell biology. It promotes the survival of activated T cells by upregulating anti-apoptotic proteins, preventing programmed cell death. Furthermore, it enhances the production of various cytokines, such as IL-2, IL-4, IL-5, and IFN-gamma, which are vital for orchestrating effective immune responses. This sustained T-cell activity is essential for clearing pathogens and eliminating cancerous cells.

The CD134 biological significance is profound, as its dysregulation is implicated in a range of immune-mediated diseases. In autoimmune conditions, excessive CD134 signaling can contribute to the persistence of autoreactive T cells, exacerbating inflammation and tissue damage. Conversely, in cancer, enhancing CD134 signaling can boost anti-tumor immunity, leading to tumor regression. This dual role makes CD134 and its ligand attractive targets for therapeutic modulation, with ongoing research exploring agonists to treat cancer and antagonists for autoimmune diseases.